UPDATED 20.02.2014 12:58

Organised cervical cancer screening programme in the Helsinki region in Finland in the invitation year 2004. Numbers and percentage distribution of primary screening test results, referrals for further examinations, and histological diagnosis of the cervix uteri.

Screening Screened Referral Histological diagnosis
test     Invasive
carcinoma
Microinvasive
carcinoma
Carcinoma
in situ
Dysplasia
gravis
Dysplasia
moderata
Dysplasia
levis
Other or
normal
  n n % n % n % n % n % n % n % n %
Pap test1 56123 586 1.04 5 0.01 4 0.01 5 0.01 46 0.08 105 0.19 64 0.11 357 0.64
I 51440 - - - - - - - - - - - - - - - -
II 4073 67 0.12 1 - - - 1 - 1 - 5 0.01 2 - 57 0.10
III 475 473 0.84 4 0.01 - - 1 - 26 0.05 88 0.16 59 0.11 295 0.53
IV 44 44 0.08 - - 3 0.01 3 0.01 19 0.03 12 0.02 3 0.01 4 0.01
V 2 2 - - - 1 - - - - - - - - - 1 -
Inadequate 89 - - - - - - - - - - - - - - - -
Unknown - - - - - - - - - - - - - - - - -
HPV test 14606 187 1.28 4 0.03 - - 1 0.01 13 0.09 48 0.33 32 0.22 89 0.61
Negative1 13452 8 0.05 - - - - 1 0.01 - - - - 1 0.01 6 0.04
Positive2 1154 179 1.23 4 0.03 - - - - 13 0.09 48 0.33 31 0.21 83 0.57
Total 70729 773 1.09 9 0.01 4 0.01 6 0.01 59 0.08 153 0.22 96 0.14 446 0.63

1 Women with Papanicolaou class I or II negative HPV test are not referred for further examinations unless repeated cytology or other results are suggestive of cancer.
2 Women whose HPV test is positive are referred for further examinations on the basis of cytology or a repeatedly positive result.